GlassScriptPhysician profile
Joshua R Noerr
NPI 1972054278
$1,425.08
in general payments reported to CMS, 2019-2025
14 companies · $283 in 2025
The $283 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.50 · 2022: $512 · 2023: $239 · 2024: $379 · 2025: $283.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $601 · Education: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $600.62 |
| Education | $300.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $385.61 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $307.28 | 2022-2025 | Nucala |
| Sanofi-Aventis U.S. LLC | $193.94 | 2023-2024 | |
| Genzyme Corporation | $193.07 | 2022-2025 | |
| Optinose US, INC. | $78.65 | 2022-2023 | |
| Ars Pharmaceuticals Operations, INC. | $73.15 | 2025 | Neffy |
| Stryker Corporation | $47.27 | 2024 | Clarifix Cryotherapy Device, Xerogel Nasal/Epistaxis 2 Pack, Nasopore |
| Janssen Pharmaceuticals, INC | $40.95 | 2022 | |
| Kaleo, INC. | $33.34 | 2022 | |
| Medtronic, INC. | $16.36 | 2022 | |
| Acclarent, INC | $15.89 | 2022 | |
| Olympus America INC. | $13.96 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.11 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Noerr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.